Position in JNJ
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$5,838,516
+$544,191 QoQ
Shares Held
22,989
+6.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.77%
of 13F equity value
Holder Rank
#1,499
of 4,664 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bridgewater Advisors Inc. holds $24,557,436 across 14 Drug Manufacturers - General names. JNJ ranks #1 (23.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
22,989 | $5,838,516 | |
| 2 | LLY |
ELI LILLY & Co
|
3,983 | $4,777,330 | |
| 3 | MRK |
Merck & Co., Inc.
|
23,905 | $3,071,792 | |
| 4 | ABBV |
AbbVie Inc.
|
9,702 | $2,441,411 | |
| 5 | AMGN |
Amgen Inc
|
5,459 | $1,976,813 | |
| 6 | NVS |
Novartis AG
|
10,369 | $1,625,029 | |
| 7 | PFE |
Pfizer Inc
|
62,287 | $1,499,870 | |
| 8 | AZN |
Astrazeneca PLC
|
4,442 | $842,292 |
All Filings in JNJ
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,838,516 | 22,989 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $5,294,325 | 21,659 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $4,677,897 | 22,604 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $4,212,371 | 22,718 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,424,807 | 22,421 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $3,948,484 | 23,809 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $3,224,013 | 22,293 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $5,070,209 | 31,286 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $3,413,128 | 23,352 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $2,573,593 | 16,269 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $2,578,059 | 16,448 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $2,500,877 | 16,057 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $2,677,286 | 16,175 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $2,495,965 | 16,103 | Shares | Sole | 2023-04-13 | |
| 2022-12-31 | $2,846,538 | 16,114 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $3,683,604 | 22,549 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $2,924,299 | 16,474 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $2,937,055 | 16,572 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $2,976,446 | 17,399 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $2,963,525 | 18,350 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $4,729,191 | 28,707 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $4,217,714 | 25,663 | Shares | Sole | 2021-05-20 | |
| No filing history on record for this holder in this stock. | ||||||